Delivery Order SPE2DB22D1106-SPE2DB25FFDK6
- Not listed
- The Defense Logistics Agency (DLA) awarded a $18,151.80 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector medication, with a completion date of September 8, 2025. The contract was competitively awarded on September 5, 2025, with no set-aside designation, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $4,980.90 delivery order on July 14, 2025, for TALTZ 80 mg/ml autoinjector medication, with performance completion targeted for July 15, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and...
- The Defense Logistics Agency awarded a delivery order valued at $14,519.43 to AmerisourceBergen Drug Corp for supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation, issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $28,410.76 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed price delivery order, with an ultimate completion date of August 21, 2025, was awarded on August 20, 2025, with no set-aside designation. The contract represents a competitive award under AmerisourceBergen's larger federal contracting relationship with DLA and reflects...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector medication, valued at $3,320.62 with a firm fixed price structure. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-competitive, non-set-aside delivery order. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $31,833.56 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical products, with an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $3,320.62 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $54,688.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical products. This is a non-set-aside competitive award with a completion date of September 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $15,780.47 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical supplies. This firm fixed price contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDK6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,628.66 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector medication, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued on August 14, 2025, with the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle that runs through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order for the specialized auto-injector medication exemplifies the company's role in supplying specialty pharmaceuticals and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The broader IDC vehicle under which this award was issued demonstrates DLA's reliance on established prime vendors to efficiently deliver a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.6k | 8/14/25 |